Volume | 253,519 |
|
|||||
News | (2) | ||||||
Day High | 29.8468 | Low High |
|||||
Day Low | 29.07 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Harmony Biosciences Holdings Inc | HRMY | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
29.07 | 29.07 | 29.8468 | 29.40 | 28.87 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,320 | 253,519 | US$ 29.31 | US$ 7,431,669 | - | 18.6112 - 39.265 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
16:22:18 | formt | 100 | US$ 29.525 | USD |
Harmony Biosciences Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.67B | 56.77M | - | 582.02M | 128.85M | 2.27 | 12.97 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Harmony Biosciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRMY Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 29.59 | 30.29 | 28.57 | 29.36 | 257,273 | -0.065 | -0.22% |
1 Month | 31.79 | 32.37 | 28.57 | 30.19 | 312,289 | -2.27 | -7.12% |
3 Months | 31.27 | 34.44 | 28.14 | 30.69 | 416,633 | -1.75 | -5.58% |
6 Months | 29.46 | 35.395 | 28.14 | 31.52 | 419,528 | 0.065 | 0.22% |
1 Year | 35.16 | 39.265 | 18.6112 | 30.83 | 528,345 | -5.64 | -16.03% |
3 Years | 32.18 | 62.085 | 18.6112 | 38.70 | 523,679 | -2.66 | -8.25% |
5 Years | 36.50 | 62.085 | 18.6112 | 38.42 | 452,240 | -6.98 | -19.11% |
Harmony Biosciences Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |